Skip to content
← Holders

GordonMD Global Investments LP

What GordonMD Global Investments LP reported holding on Form 13F for the quarter ended Sep 30, 2026.

CIK 2039349 · Filed Nov 16, 2026

Positions
14
Reported value
$166.5M
Opened
3
Closed
5
Other managers included
0

Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR

Quarters on file

  1. Dec 31, 2025$139.5M
    13 positions
  2. Mar 31, 2026$143.6M
    16 positions
  3. Jun 30, 2026$206.7M
    16 positions
  4. Sep 30, 2026$166.5M
    14 positions
SecuritySharesChangeValueOf portfolio
PYXSPyxis Oncology, Inc.
15.5M+55.0%$36.2M21.8%
KYTXKyverna Therapeutics, Inc.
4.5M+6.5%$30.7M18.5%
TEVATeva Pharmaceutical Industries Ltd
379.5KNew$15M9%
CLDXCelldex Therapeutics, Inc.
279.7K±0%$9.1M5.4%
TNGXTango Therapeutics, Inc.
1.9MNew$9M5.4%
VIRVir Biotechnology, Inc.
803.6K−40.6%$9M5.4%
ADRXADARx Pharmaceuticals, Inc.
450KNew$9M5.4%
ALLOAllogene Therapeutics, Inc.
5.3M±0%$8.5M5.1%
BLCOBausch & Lomb Corp
475.5K−17.1%$8.1M4.9%
EDITEditas Medicine, Inc.
3.1M±0%$8M4.8%
INCYIncyte Corp
51.1K+18.0%$6.2M3.7%
TSHATaysha Gene Therapies, Inc.
248K−65.7%$6.2M3.7%
AMGNAmgen Inc
14.5K−28.2%$6.1M3.7%
SRRKScholar Rock Holding Corp
110.5K−16.6%$5.3M3.2%